Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,165,851
-
Share change
-
+190,943
-
Total reported value
-
$15,208,863
-
Put/Call ratio
-
55%
-
Price per share
-
$1.66
-
Number of holders
-
61
-
Value change
-
-$99,206
-
Number of buys
-
34
-
Number of sells
-
26
Institutional Holders of Protalix BioTherapeutics, Inc. - COM (PLX) as of Q3 2023
As of 30 Sep 2023 Protalix BioTherapeutics, Inc. - COM (PLX) had 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,165,851 shares of stock of the company.
Largest 10 holders included BlackRock Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, GSA CAPITAL PARTNERS LLP, NORTHERN TRUST CORP, VANGUARD GROUP INC, Nuveen Asset Management, LLC, MORGAN STANLEY, and BANK OF AMERICA CORP /DE/.
This table shows 61 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.